JCRファーマJP:4552損益計算書

時価総額
¥916.9億
PER
29.2倍
医療用医薬品や再生医療等製品の製造・販売、医療機器の仕入・販売、臨床オペレーションや薬事業務を展開する企業。
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
売上高12,84514,10015,70616,85617,43818,08520,59423,16024,78130,08551,08234,34342,87133,072
売上原価---5,7416,4595,7326,1286,5677,9017,81210,4618,88611,62011,333
売上総利益---11,11510,97912,35314,46516,59216,88022,27240,62025,45631,25121,738
売上総利益率(%)---
営業利益---2,0152,1532,3623,7844,9673,2448,26919,9334,9757,531-6,650
営業費用---9,1008,8269,99110,68111,62513,63514,00320,68620,48023,71928,389
経常(税引前)利益1,0051,1561,6812,3402,4432,5343,8435,0683,2938,48820,5125,4187,264-7,477
法人税等合計---6526706308251,2177421,7644,8861,6251,707-1,718
純利益6505531,1801,6821,7901,8633,0703,7152,6796,89214,5173,7875,536-4,695
一株あたり利益19.7523.0340.7952.8556.1258.9598.73120.6886.8955.81117.2630.3544.13-38.43
希薄化後一株あたり利益19.6922.9240.5252.5355.8158.6198.11119.9686.3655.53116.830.2243.92-
配当性向(%)----------
一株あたり配当金12121718.5222226303225.522202020